Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,8612,880 of 20,252 grants

Active NON-SBIR/STTR RPGS
Targeting MALT1 to Enhance Anti-Lymphoma Immunity and Response to Immunotherapy
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is the most frequent B-cell non-Hodgkin lymphoma (B-NHL). The treatment of these diseases remains challenging, with many patients ult...

$4.55M
USD
Completed SBIR-STTR RPGS
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
NATIONAL CANCER INSTITUTE Nanometics, Llc United States 2023 – 2025

PROJECT SUMMARY / ABSTRACT Acinic Keratoses (AK) are premalignant skin lesions with the potential to develop into Cutaneous Squamous cell Carcinoma (CSCC), which is the second most...

$10M
USD
Active NON-SBIR/STTR RPGS
A Bioprinted Volumetric Model of Vascularized Glioblastoma
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

Abstract The dynamic tumor microenvironment (TME) where cells continuously communicate, migrate, and react to each other and the signals that are secreted, is critical for inducing...

$4.05M
USD
Active SBIR-STTR RPGS
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
NATIONAL CANCER INSTITUTE Eximius Diagnostics Corp United States 2023 – 2026

PROJECT SUMMARY Hepatocellular carcinoma (HCC) comprises 80-85% of primary liver cancers and frequently develops in patients with liver cirrhosis or chronic hepatitis B virus infec...

$6.62M
USD
Active TRAINING, INSTITUTIONAL
Training Grant in Precision Cancer Control
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2023 – 2028

PROJECT SUMMARY In the United States, more than 40 percent of new cancer cases can be attributed to modifiable factors. Yet, despite advances in knowledge regarding the multilevel...

$3.38M
USD
Completed OTHER RESEARCH-RELATED
Dissecting the role of mitochondrial glutathione homeostasis in cancer
NATIONAL CANCER INSTITUTE Rockefeller University United States 2023 – 2025

Project Summary All eukaryotic cells, whether normal or cancerous, require the ability to sense changes in nutrients levels, ensuring their efficient use for survival and growth. N...

$489.7K
USD
Active OTHER RESEARCH-RELATED
Summer Program for Academic Research in Cancer (SPARC)
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2028

The objective of the proposed Summer Program for Academic Research in Cancer (SPARC) at the Indiana University Simon Comprehensive Cancer Center (IUSCCC) is to provide cancer resea...

$2.96M
USD
Active OTHER RESEARCH-RELATED
University of Kansas Cancer Center Paul Calabresi K12 Career Development Award for Clinical Oncology
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2023 – 2028

ABSTRACT We propose to develop The University of Kansas Cancer Center (KUCC) Paul Calabresi K12 Career Development Award for Clinical Oncology (“KUCC K12 Program”), whose primary g...

$540K
USD
Active NON-SBIR/STTR RPGS
Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT A molecular imaging revolution is underway in prostate cancer. To overcome longstanding limitations in prostate cancer staging, several positron-emission t...

$6.6M
USD
Active NON-SBIR/STTR RPGS
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

Project Summary/Abstract In 2014, the state of Maryland, under a federal waiver, enacted an all-payer Global Budget Revenue (GBR) model that prospectively set limits on hospital re...

$6.24M
USD
Completed OTHER RESEARCH-RELATED
Transposable Elements at the Crossroads of Evolution, Health and Disease
NATIONAL CANCER INSTITUTE Keystone Symposia United States 2023 – 2024

ABSTRACT Support is requested for a Keystone Symposia conference entitled Transposable Elements at the Crossroads of Evolution, Health and Disease, organized by Drs. Kathleen Burns...

$150K
USD
Completed NON-SBIR/STTR RPGS
Measuring Gender in the Healthy Oregon Project
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2023 – 2025

PROJECT SUMMARY The sexual and gender minority (SGM) community (i.e., LGBTQ+) is vastly underrepresented in cancer research. As such, there are limited data on cancer-related healt...

$1.62M
USD
Active NON-SBIR/STTR RPGS
Cloud Enabled, Rigorous, Functional Assay Calibration (CERFAC)
NATIONAL CANCER INSTITUTE University of Utah United States 2023 – 2027

SUMMARY The use of gene sequencing to identify pathogenic sequence variants of high-risk disease susceptibility genes began in the mid-late 1990s. In about 2010, the technology use...

$2.2M
USD
Active OTHER RESEARCH-RELATED
Summer Program for Academic Research in Cancer (SPARC)
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2028

The objective of the proposed Summer Program for Academic Research in Cancer (SPARC) at the Indiana University Simon Comprehensive Cancer Center (IUSCCC) is to provide cancer resea...

$2.85M
USD
Active NON-SBIR/STTR RPGS
Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT A molecular imaging revolution is underway in prostate cancer. To overcome longstanding limitations in prostate cancer staging, several positron-emission t...

$6.29M
USD
Active OTHER RESEARCH-RELATED
University of Kansas Cancer Center Paul Calabresi K12 Career Development Award for Clinical Oncology
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2023 – 2028

ABSTRACT We propose to develop The University of Kansas Cancer Center (KUCC) Paul Calabresi K12 Career Development Award for Clinical Oncology (“KUCC K12 Program”), whose primary g...

$2.57M
USD
Active NON-SBIR/STTR RPGS
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

Project Summary/Abstract In 2014, the state of Maryland, under a federal waiver, enacted an all-payer Global Budget Revenue (GBR) model that prospectively set limits on hospital re...

$4.94M
USD
Completed NON-SBIR/STTR RPGS
A phase-1 trial of intraperitoneal 5-fluorouracil and oxaliplatin in patients with colorectal cancer and unresectable peritoneal metastasis.
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2025

SUMMARY Patients with colorectal cancer (CRC) and peritoneal metastases (PM) have significantly worse outcomes than metastases to other sites like the lungs or liver. In patients w...

$3.36M
USD
Completed NON-SBIR/STTR RPGS
Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2025

Abstract Current strategies to prevent ovarian cancer deaths remain limited. Unlike breast and colon cancer, clinical trials for early detection of ovarian cancer have not been eff...

$1.79M
USD
Completed OTHER RESEARCH-RELATED
Investigating mitochondrial dysfunction in high-risk prostate cancer
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2025

Project Summary/Abstract Prostate cancer incidence in the United States has significantly increased over the last two decades. Despite the improvement of screening strategies, it r...

$1.36M
USD